1. Analyst View
2. Macroeconomic and Healthcare Factors
2.1 Macroeconomic Indicators
2.2 Population Profile
2.3 Age Profile
2.4 Healthcare Spending and Infrastructure
3. Market Trends
3.1 More Generic Drugs for Hypertension
3.2 Generics Getting Affordable
3.3 Patent Expiration
4. Generics Market Performance
4.1 Market Size and Growth
4.1.1 Prescriptions
4.1.2 Sales
4.2 By Province/Territories
4.2.1 Drug Consumption
4.2.2 Prescriptions
4.2.3 Sales
4.3 By Distribution
4.3.1 Retail Pharmacies
4.3.2 Hospital Pharmacies
4.3.3 Authorized and Independent Generics
4.3.4 Distribution Channels
4.4 By Disease
4.4.1 Cardiovascular Drugs
4.4.2 Psychotherapeutics
4.4.3 Cholesterol Agents
4.4.4 Neurological Agents
4.4.5 Antidiabetics
5. Regulatory Environment
6. Competitive Landscape
6.1 Market Structure
6.2 Key Players Analysis
6.2.1 Apotex
6.2.2 Teva Canada Ltd. (Novopharm)
6.2.3 Mylan
6.2.4 Pharmascience
